tradingkey.logo
tradingkey.logo
Search

Zimmer Biomet Holdings Inc

ZBH
Add to Watchlist
95.360USD
+1.110+1.18%
Close 09-18 16:00ET
18.18BMarket Cap
24.66P/E TTM
After-hours 19:00 (ET)95.360USD+0.080+0.08%

Zimmer Biomet Holdings Inc (ZBH) Stock Price Target & Forecast

Analyst Rating

Based on 29 analysts giving stock ratings to Zimmer Biomet Holdings Inc in the past month.

Hold
2 Strong Buy
6 Buy
21 Hold
0 Sell
0 Strong Sell
Target Price
106.873USD+13.39%

ZBH Analyst Recommendation Trends

In the current month, ZBH has received 6 Buy Ratings, 21 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the last month is 106.873.

2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
2
2
3
3
2
2
3
3
Buy
6
6
6
6
6
6
6
6
Hold
21
21
19
19
20
19
19
18
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
2
2
3
3
3
3
Total
29
29
30
30
31
30
31
30

ZBH Analyst Rating for Peer Comparison

Updated: Sep 19, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Abbott Laboratories
ABT
11
11
7
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
West Pharmaceutical Services Inc
WST
6
12
1
0
0
19

Financial Forecasting

Based on analysts' estimates, ZBH EPS is projected to reach 1.883 in FY2026Q3, following reported EPS of 1.032 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.40
1.86
2.01
1.88
2.49
Actual
0.71
1.22
1.03
--
--
Surprise
-70.50%
-34.51%
-48.65%
--
--

FAQs

What is Zimmer Biomet Holdings Inc's expected revenue for the next quarter?

Zimmer Biomet Holdings Inc's expected revenue is 2.04B.

What is Zimmer Biomet Holdings Inc's price target?

Analysts forecast that Zimmer Biomet Holdings Inc's price target is USD 106.87, with the highest forecast at USD 129.34 and the lowest forecast at USD 93.00.

How have Zimmer Biomet Holdings IncZBH's recent earnings per share performed?

The market expectation was USD 1.03, while Zimmer Biomet Holdings IncZBH's earnings per share (EPS) for the previous quarter was USD 1.22. EPS for the next quarter is expected at USD 1.88.

What is the analyst rating for Zimmer Biomet Holdings Inc?

Based on the ratings of Zimmer Biomet Holdings Inc's stock from 29 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.